Department of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Department of Ophthalmology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
J Ocul Pharmacol Ther. 2020 Jul/Aug;36(6):458-466. doi: 10.1089/jop.2020.0028. Epub 2020 Jun 18.
To determine the baseline choroid-retina fluorescence signal in Royal College of Surgeon (RCS) rats of various ages with different degrees of retinal degeneration and assess the persistence of intravitreal nanoparticles. In RCS rats of age 6, 12, and 20 weeks and Sprague Dawley (SD) rats of age 6 and 20 weeks, baseline eye tissue fluorescence and retinal thickness were recorded noninvasively using fluorophotometry and optical coherence tomography (OCT), respectively. Further, 20-nm carboxylate-modified fluorescent particles were injected intravitreally in the above groups of rats, and the depth-wise fluorescence signal was monitored over 7 days using fluorophotometry and confocal laser scanning ophthalmoscopy (cSLO). Additionally, 200 nm particles of the same material were injected intravitreally into about 7-week-old RCS rats and the fluorescence signal was monitored up to 35 days using fluorophotometry. Reduction in retinal thickness and an increase in choroid-retina and lens baseline fluorescence was observed with increasing age of RCS and SD rats. The 20 nm particles persisted in the vitreous of animals from all age groups for at least 7 days postadministration, irrespective of the differences in retinal thickness. cSLO confirmed nanoparticle persistence in the eye. The fluorescence signal from 200 nm particles persisted for 35 days in the vitreous humor. Choroid-retina and lens autofluorescence monitored using fluorophotometry increase with age. Intravitreally injected nanoparticles can be monitored noninvasively in rats using fluorophotometry and cSLO imaging. Both 20 and 200 nm particles persist in the back of the eye tissues, for several days following intravitreal injection.
确定不同年龄、不同程度视网膜变性的皇家外科学院(RCS)大鼠的脉络膜-视网膜荧光信号基线,并评估玻璃体内纳米颗粒的持续存在情况。
在年龄为 6、12 和 20 周的 RCS 大鼠以及年龄为 6 和 20 周的 Sprague Dawley(SD)大鼠中,分别使用荧光光度法和光学相干断层扫描(OCT)非侵入性地记录基线眼组织荧光和视网膜厚度。进一步,将 20nm 羧基修饰荧光颗粒注射到上述各组大鼠的玻璃体内,并用荧光光度法和共聚焦激光扫描检眼镜(cSLO)监测 7 天内的深度荧光信号。此外,将相同材料的 200nm 颗粒注射到大约 7 周龄的 RCS 大鼠的玻璃体内,并使用荧光光度法监测长达 35 天的荧光信号。
随着 RCS 和 SD 大鼠年龄的增加,观察到视网膜厚度降低,脉络膜-视网膜和晶状体的基线荧光增加。20nm 颗粒在所有年龄组动物的玻璃体内至少持续 7 天,与视网膜厚度的差异无关。cSLO 证实了纳米颗粒在眼内的持续存在。200nm 颗粒的荧光信号在玻璃体内持续 35 天。
荧光光度法监测到的脉络膜-视网膜和晶状体自发荧光随年龄增长而增加。使用荧光光度法和 cSLO 成像可以非侵入性地监测玻璃体内注射的纳米颗粒。20nm 和 200nm 颗粒在玻璃体内注射后数天内在眼后组织中持续存在。